Sarsia is a venture capital fund based in Bergen, Norway, focusing on biotech and pharma companies at the Series A stage. Leveraging extensive expertise and a broad network of industry and co-investors, Sarsia provides strategic guidance and funding to early-stage companies. Established in 2007 with Sarsia Seed Fund I, the firm has generated significant shareholder value. It launched Sarsia Seed Fund II in 2017 and Sarsia Fund III in 2023, continuing its commitment to growth in the biotech sector. Notable investments include Calluna Pharma.
